Broad Pipeline Designed with Multiple Mechanisms of Action

home-page-broad-pipeline
Lead Candidate Mipletamig: In the Fight Against Acute Myeloid Leukemia
aptevo-pipeline-drug
Why Aptevo: View the Corporate Presentation
Aptevo-NASDAQ
Meeting Milestones:  Latest News & Accomplishments
aptevo-news

Aptevo: Developing Meaningful Therapeutics that Produce Promising Outcomes in the Fight Against Cancer

Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel bispecific immunotherapies for the treatment of cancer. Aptevo is seeking to improve treatment outcomes and transform the lives of cancer patients.